Results 21 to 30 of about 45,582 (279)

Immune Response Modulation by Tumor-Secreted Glycosphingolipids [PDF]

open access: yes, 2014
Although originally considered merely structural components of cellular membranes, glycosphingolipids (GSL) arenow recognized as having critical effects on cellular physiology, including proliferation, differentiation, viraltransformation and ontogenesis.
Cely, Ingrid   +3 more
core   +1 more source

Entirely Carbohydrate-Based Vaccines: An Emerging Field for Specific and Selective Immune Responses

open access: yesVaccines, 2016
Carbohydrates are regarded as promising targets for vaccine development against infectious disease because cell surface glycans on many infectious agents are attributed to playing an important role in pathogenesis.
Sharmeen Nishat, Peter R. Andreana
doaj   +1 more source

Altered Glycosylation in Progression and Management of Bladder Cancer

open access: yesMolecules, 2023
Bladder cancer (BC) is the 10th most common malignancy worldwide, with an estimated 573,000 new cases and 213,000 deaths in 2020. Available therapeutic approaches are still unable to reduce the incidence of BC metastasis and the high mortality rates of ...
Magdalena Wilczak   +2 more
doaj   +1 more source

Glyco-biomarkers: Potential determinants of cellular physiology and pathology [PDF]

open access: yes, 2008
Once dismissed as just the icing on the cake, sugar molecules are emerging as vital components in life’s intricate machinery. Our understanding of their function within the context of the proteins and lipids to which they are attached has matured rapidly,
Alavi, A, Axford, JS
core   +2 more sources

Carbohydrate Mimetic Peptides for Pan Anti-Tumor Responses

open access: yesFrontiers in Immunology, 2014
Molecular mimicry is fundamental to biology which transcends to many disciplines ranging from immune pathology to drug design. Structural characterization of molecular partners has provided insight into the origins and relative importance of ...
Thomas eKieber-Emmons   +4 more
doaj   +1 more source

A practical approach to pancreatic cancer immunotherapy using resected tumor lysate vaccines processed to express α-gal epitopes. [PDF]

open access: yesPLoS ONE, 2017
Single-agent immunotherapy is ineffective against poorly immunogenic cancers, including pancreatic ductal adenocarcinoma (PDAC). The aims of this study were to demonstrate the feasibility of production of novel autologous tumor lysate vaccines from ...
Kenta Furukawa   +15 more
doaj   +1 more source

Anomeric O-Functionalization of Carbohydrates for Chemical Conjugation to Vaccine Constructs. [PDF]

open access: yes, 2018
Carbohydrates mediate a wide range of biological interactions, and understanding these processes benefits the development of new therapeutics. Isolating sufficient quantities of glycoconjugates from biological samples remains a significant challenge ...
Gervay-Hague, Jacquelyn   +2 more
core   +1 more source

Carbohydrate receptor-mediated gene transfer to human T leukaemic cells [PDF]

open access: yes, 1994
The mucin-type carbohydrate Tn cryptantigen (GalNAcα1-O-Ser/Thr, where GalNAc is N-acetyl-D-galactosamine) is expressed in many carcinomas, in haemopoietic disorders including the Tn syndrome, and on human immunodeficiency virus (HIV) coat glycoproteins,
Berger, Eric G.   +8 more
core   +2 more sources

Tumor derived Microvesicles enhance cross-processing ability of clinical grade Dendritic Cells [PDF]

open access: yes, 2018
Tumor cells release extracellular microvesicles (MVs) in the microenvironment to deliver biological signals to neighbouring cells as well as to cells in distant tissues.
Battisti, Federico   +11 more
core   +1 more source

Cancer vaccine with mimotopes of tumor-associated carbohydrate antigens [PDF]

open access: yesImmunologic Research, 2009
The GD2 ganglioside, displayed by five carbohydrate Neu5Acalpha2-8Neu5Acalpha2-3(GalNAcbeta1-4)Galbeta1-4Glcbeta residues attached to a ceramide chain that anchors the ganglioside in the cell membrane, is expressed on neuroectodermally derived tumors. GD2 has been used as a target for passive and active immunotherapy in patients with malignant melanoma
openaire   +2 more sources

Home - About - Disclaimer - Privacy